Skip to main content

Table 1 Parameters of study participants at baseline

From: Effect of the angiotensin receptor blocker irbesartan on metabolic parameters in clinical practice: the DO-IT prospective observational study

Parameter

All

Men

Women

n

3259

64.1%

35.9%

Age [years]

61.5 ± 10.5

60.2 ± 10.0

63.7 ± 10.8*

BMI [kg/m2]

30.9 ± 4.8

30.8 ± 4.4

31.0 ± 5.3

Waist-circumference [cm]

106.4 ± 13.6

110.2 ± 11.9

99.2 ± 13.7*

RRsystolic [mmHg]

157.4 ± 14.7

157.5 ± 14.5

157.2 ± 15.1

RRdiastolic [mmHg]

92.9 ± 9

93.3 ± 9.1

92.2 ± 9.5*

Fasting plasma glucose (FPG) [mg/dl]

126.4 ± 37.1

126.6 ± 37.3

126.0 ± 36.7

LDL-cholesterol [mg/dl]

144.9 ± 38.2

144.8 ± 38.5

145.2 ± 37.5

HDL-cholesterol [mg/dl]

48.4 ± 31.8

46.2 ± 30.9

52.6 ± 33.2*

Triglycerides [mg/dl]

217.4 ± 114.9

221.1 ± 127.7

209.9 ± 85.8*

Hs-CRP [mg/l]

4.81 ± 7.95

5.13 ± 8.38

3.75 ± 6.26

Gamma-GT [U/l]

52.9 ± 47.1

58.7 ± 50.6

40.6 ± 34.8*

  1. BMI = body-mass index; * p < 0.01 for intergender differences;